Corbus Pharmaceuticals Holdings, Inc.盘中异动早盘股价大跌5.42%报41.37美元

自选股智能写手05-10

北京时间2024年05月10日22时24分，Corbus Pharmaceuticals Holdings, Inc.（CRBP.us）股票出现异动，股价急速下挫5.42%。截至发稿，该股报41.37美元/股，成交量1.5911万股，换手率0.15%，振幅4.98%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.90百万美元，每股收益-0.83美元，毛利-151688.00美元，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2434857497?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-05-10 22:24","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2434857497","market":"us","top_or_hot":-1,"title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大跌5.42%报41.37美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年05月10日22时24分，Corbus Pharmaceuticals Holdings, Inc.（CRBP.us）股票出现异动，股价急速下挫5.42%。截至发稿，该股报41.37美元/股，成交量1.5911万股，换手率0.15%，振幅4.98%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.90百万美元，每股收益-0.83美元，毛利-151688.00美元，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510222420861ec736&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Corbus Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大跌5.42%报41.37美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCorbus Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大跌5.42%报41.37美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-10 22:24 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510222420861ec736&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年05月10日22时24分，Corbus Pharmaceuticals Holdings, Inc.（CRBP.us）股票出现异动，股价急速下挫5.42%。截至发稿，该股报41.37美元/股，成交量1.5911万股，换手率0.15%，振幅4.98%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.90百万美元，每股收益-0.83美元，毛利-151688.00美元，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510222420861ec736&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510222420861ec736&s=b","article_id":"2434857497","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510222420861ec736&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2434857497","pubTimestamp":1715351059,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年05月10日22时24分，Corbus Pharmaceuticals Holdings, Inc.股票出现异动，股价急速下挫5.42%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司，致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。消息层面，截至22时24分，《Form 144 | Corbus Pharmaceuticals关联方拟出售1.56万股股份，价值约63.49万美元》资讯为影响Corbus Pharmaceuticals Holdings, Inc.的重要信息。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","CRBP":"Corbus Pharmaceuticals Holdings, Inc."},"translate_title":"Corbus Pharmaceuticals Holdings, Inc. shares fell 5.42% to $41.37 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRBP":1},"content_text":"北京时间2024年05月10日22时24分，Corbus Pharmaceuticals Holdings, Inc.（CRBP.us）股票出现异动，股价急速下挫5.42%。截至发稿，该股报41.37美元/股，成交量1.5911万股，换手率0.15%，振幅4.98%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.90百万美元，每股收益-0.83美元，毛利-151688.00美元，市盈率-5.98倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，诺瓦瓦克斯医药、Clene Inc C/Wts 30/12/2025 (To Pur Com)、Estrella Immunopharma Inc C/Wts 29/09/2028(To Pur Com)涨幅较大，诺瓦瓦克斯医药、Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为70.38%、35.15%、20.78%，振幅较大的相关个股有Artelo Biosciences Inc C/Wts 20/06/2024 (To Pur Com)、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Celularity Inc C/Wts 16/07/2026 (To Pur Com)，振幅分别为44.63%、41.58%、32.95%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司，致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。 该公司的产品线包括： CRB-701 ，一种下一代抗体药物偶联物 (ADC)，会针对癌细胞上 Nectin-4 的表达，释放细胞毒性有效负载；CRB-601 ，一种抗整合素单克隆抗体，可阻断癌细胞上表达的 TGF 的激活。 CRB-913 ，一种第二代外周限制性 CB1 受体反向激动剂，旨在治疗肥胖症。消息层面，截至22时24分，《Form 144 | Corbus Pharmaceuticals(CRBP.US)关联方拟出售1.56万股股份，价值约63.49万美元》资讯为影响Corbus Pharmaceuticals Holdings, Inc.的重要信息。该信息摘要如下：根据美国证券交易委员会（SEC）美东时间5月8日披露的文件，Corbus Pharmaceuticals 关联方Brake Rachael Louise拟于5月8日出售1.56万股普通股股份，总市值约63.49万美元。其中，关联方必须持有证券至少六个月，卖出的股数不得超过已发行股份总数的1%。关联方在任何三个月期间出售的股票数量超过5,000股时，或总市值超5万美元时须向SEC提交该表格。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2434857497"}

Corbus Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大跌5.42%报41.37美元

精彩评论

Corbus Pharmaceuticals Holdings, Inc.盘中异动早盘股价大跌5.42%报41.37美元